CTI BIOPHARMA CORP Human Resources Contracts & Agreements
71 Contracts & Agreements
- Bonus & Incentive Agreements (32 contracts)
- Compensation Agreements (12)
- Consulting Agreements (1)
- Employment Agreements (10)
- Separation Agreements (3)
- Severance Agreements (13)
- Amendment No. 2 to Severance Agreement by and between James Fong and CTI BioPharma Corp (Filed With SEC on May 15, 2023)
- Amendment No. 2 to Employment Agreement by and between Adam R. Craig and CTI BioPharma Corp (Filed With SEC on May 15, 2023)
- CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on June 3, 2022)
- Amendment to Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022 (Filed With SEC on March 4, 2022)
- Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of January 6, 2015 (Filed With SEC on March 4, 2022)
- CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on June 7, 2021)
- CTI BioPharma Corp. Director Compensation Policy (Filed With SEC on May 6, 2021)
- CTI BioPharma Corp. 2017 Equity Incentive Plan Stock Option Agreement (Filed With SEC on November 10, 2020)
- Director Compensation Policy (Filed With SEC on March 13, 2020)
- CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 17, 2019)
- Director Compensation Policy (Filed With SEC on May 2, 2019)
- CTI BioPharma Corp. Executive Incentive Compensation Plan (Filed With SEC on March 13, 2019)
- Amendment to Employment Agreement, dated October 31, 2018, by and between Adam R. Craig and the Company (Filed With SEC on November 1, 2018)
- Form of Stock Option Agreement under the Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 21, 2018)
- CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 21, 2018)
- Severance Agreement by and between CTI BioPharma Corp. and David Kirske, dated September 25, 2017 (Filed With SEC on September 26, 2017)
- SEPARATION AND RELEASE AGREEMENT (Filed With SEC on August 22, 2017)
- CTI BIOPHARMA CORP. 2017 EQUITY INCENTIVE PLAN (Filed With SEC on May 16, 2017)
- CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective February 23, 2017 (Filed With SEC on May 3, 2017)
- SEPARATION AND RELEASE AGREEMENT (Filed With SEC on March 13, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2017)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on October 24, 2016)
- SEPARATION AND RELEASE AGREEMENT (Filed With SEC on October 3, 2016)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN (As Amended March 2, 2016) (Filed With SEC on April 29, 2016)
- CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective January 1, 2016 (Filed With SEC on February 17, 2016)
- SEVERANCE AGREEMENT (Filed With SEC on February 17, 2016)
- AMENDMENT NO. 3 to EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2016)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK BONUS AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)
- CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on November 5, 2015)
- CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective July 27, 2015 (Filed With SEC on November 5, 2015)
- CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (GLOBAL FORM) (Filed With SEC on March 12, 2015)
- CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on March 12, 2015)
- CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 12, 2015)
- SEVERANCE AGREEMENT (Filed With SEC on March 12, 2015)
- AMENDMENT NO. 2 to EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)
- CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN Effective as of June20, 2003 and amended and restated as of September 17, 2014 SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on October 31, 2014)
- CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on October 30, 2013)
- CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN STOCK AWARD AGREEMENT (Filed With SEC on October 30, 2013)
